Clinical trial
Safety, Tolerability and Efficacy of Coenzyme Q10 in Hemodialysis Patients: Aim 1
NCT00908297 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety, Tolerability and Efficacy of Coenzyme Q10 in Hemodialysis Patients: Aim 1
- Lead sponsor
- University of Washington
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- November 30, 2010
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, cardiovascular disease, end stage renal disease, oxidative stress